Teva Pharmaceutical Industries Limited
TEVA
$16.71
$0.382.33%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.30B | 3.32B | 2.26B | 2.99B | 3.23B |
| Total Receivables | 3.06B | 3.46B | 3.77B | 3.46B | 3.41B |
| Inventory | 3.01B | 3.96B | 3.93B | 3.95B | 4.02B |
| Prepaid Expenses | 1.01B | 1.13B | 1.10B | 1.34B | 1.26B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.18B | 447.00M | 585.00M | 565.00M | 575.00M |
| Total Current Assets | 12.55B | 12.31B | 11.63B | 12.30B | 12.49B |
|
|
|||||
| Total Current Assets | 12.55B | 12.31B | 11.63B | 12.30B | 12.49B |
| Net Property, Plant & Equipment | 4.95B | 6.04B | 5.93B | 5.98B | 6.15B |
| Long-term Investments | 15.15B | 16.12B | 16.49B | 17.01B | 17.18B |
| Goodwill | 15.15B | 16.12B | 16.49B | 17.01B | 17.18B |
| Total Other Intangibles | 4.42B | 4.76B | 4.85B | 5.06B | 5.39B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.26B | 2.53B | 2.43B | 2.43B | 2.28B |
| Total Assets | 39.33B | 41.76B | 41.34B | 42.77B | 43.48B |
|
|
|||||
| Total Accounts Payable | 2.20B | 2.37B | 2.37B | 2.44B | 2.60B |
| Total Accrued Expenses | 5.65B | 5.98B | 5.64B | 5.47B | 5.53B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.87B | 2.58B | 2.09B | 3.06B | 1.77B |
| Total Finance Division Other Current Liabilities | 3.07B | 2.86B | 2.94B | 2.82B | 2.35B |
| Total Other Current Liabilities | 3.07B | 2.86B | 2.94B | 2.82B | 2.35B |
| Total Current Liabilities | 12.80B | 13.80B | 13.04B | 13.79B | 12.25B |
|
|
|||||
| Total Current Liabilities | 12.80B | 13.80B | 13.04B | 13.79B | 12.25B |
| Long-Term Debt | 16.00B | 16.40B | 16.55B | 16.58B | 18.16B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 314.00M | 295.00M | 281.00M | 294.00M | 343.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.49B | 4.88B | 4.91B | 4.56B | 4.60B |
| Total Liabilities | 33.61B | 35.37B | 34.78B | 35.23B | 35.35B |
|
|
|||||
| Common Stock & APIC | 27.82B | 27.92B | 27.89B | 27.85B | 27.86B |
| Retained Earnings | -15.17B | -14.96B | -14.52B | -13.67B | -13.53B |
| Treasury Stock & Other | -7.28B | -6.90B | -7.01B | -6.90B | -6.82B |
| Total Common Equity | 5.37B | 6.07B | 6.36B | 7.28B | 7.51B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.37B | 6.07B | 6.36B | 7.28B | 7.51B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 347.00M | 319.00M | 204.00M | 265.00M | 620.00M |
| Total Equity | 5.72B | 6.38B | 6.56B | 7.54B | 8.13B |
|
|
|||||
